The University of Kansas Cancer Center — Kansas City, Kansas

The University of Kansas Cancer Center is a clinical research site located in Kansas City, Kansas, United States 66160.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

The University of Kansas Cancer Center has participated in 12 clinical trials with 7 currently active.

Therapeutic areas: Chronic Myeloid Leukemia, Advanced Solid Tumor, Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL).

Sponsors: Deciphera Pharmaceuticals, LLC, MediLink Therapeutics (Suzhou) Co., Ltd., Kite, A Gilead Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Kansas · View every site in Kansas City

• University of Kansas Med Ctr; Int med/Allgy/Immun/Rheum
• University of Kansas Hospital-Hospital
• University of Kansas Medical Center; Department of Hematology
• The University of Kansas Health
• The Marc A. Asher Comprehensive Spine Center at the Kansas University Medical Center
• University of Kansas Medical center Medical office building
• University of Kansas Medical Center CBYM338B2203
• University of Kansas Health Sy /ID# 78929
• University of Kansas Medical Center Research Institute
• The University of Kansas Clinical Research Center
• University of Kansas Hospital and Medical Center
• The University of Kansas Health System

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Cancer Center?

The University of Kansas Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Cancer Center conducted?

The University of Kansas Cancer Center has 12 clinical trials on record, with 7 currently active. Their work covers Chronic Myeloid Leukemia, Advanced Solid Tumor, Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL).

Is The University of Kansas Cancer Center accredited by Crixeo Clinical Trials?

The University of Kansas Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Kansas Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.